Drug intelligence / Profile preview

c-FLIP siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral, Intravenous
01

Overview

c-FLIP siRNA is an experimental small interfering RNA (siRNA) designed to silence the expression of Cellular FLICE-like Inhibitory Protein (c-FLIP), a key regulator of the extrinsic apoptotic pathway. c-FLIP acts as a catalytically inactive homolog of caspase-8 and caspase-10, competing for binding at the death-inducing signaling complex (DISC) and thereby preventing pro-apoptotic signaling. By downregulating c-FLIP, this siRNA restores sensitivity to apoptosis-inducing ligands like TRAIL and enhances the cytotoxic effects of various chemotherapeutic agents. It has been extensively studied in preclinical models of various malignancies, including cervical, breast, and prostate cancers, to overcome resistance to programmed cell death. It is primarily used as a research reagent and is not currently associated with a single commercial drug development program.

Other names
CFLAR siRNAcellular FLICE-like inhibitory protein siRNA
02

Targets

CFLAR (CASP8 and FADD-like apoptosis regulator)

Beyond the preview

Go deeper on c-FLIP siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on c-FLIP siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call